Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods

Annals of the New York Academy of Sciences

Volumn 1109, Issue , 2007, Pages 245-255

  Desplat Jego, Sophie ^a   Bardin, Nathalie ^a   Larida, Bruno ^b   Sanmarco, Marielle ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

^b BIO RAD LABORATORIES   (United States)

Author keywords

Anti dsDNA antibodies; Antiextractable nuclear antigen antibodies; Antinuclear antibodies; Luminex based assay

Indexed keywords

ANTINUCLEAR ANTIBODY; CELL NUCLEUS ANTIGEN; DOUBLE STRANDED DNA ANTIBODY; LA ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RIBOSOME PROTEIN; RO ANTIBODY; SCL 70 ANTIBODY; SM ANTIBODY; ANTIGEN; AUTOANTIBODY;

ANTIBODY DETECTION; ANTIGEN SPECIFICITY; CENTROMERE; CHROMATIN; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; ENZYME IMMUNOASSAY; HEP 2 CELL; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNODIFFUSION; IMMUNOFLUORESCENCE TEST; KAPPA STATISTICS; MAJOR CLINICAL STUDY; SCREENING; SERUM; ARTICLE; BLOOD; COMPARATIVE STUDY; EVALUATION; IMMUNOLOGY; MASS SCREENING; METHODOLOGY; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, ANTINUCLEAR; ANTIGENS; AUTOANTIBODIES; HUMANS; MASS SCREENING; SENSITIVITY AND SPECIFICITY;

EID: 34848899292     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1398.030     Document Type: Conference Paper

References (26)

1. CATOGGIO, L.J., R.M. BERNSTEIN, C.M. BLACK, et al. 1983. Serological markers in progressive systemic sclerosis: clinical correlations. Ann. Rheum. Dis. 42: 23-27.
2. FERNANDEZ-MADRID, F. & M. MATTIOLI. 1976. Antinuclear antibodies (ANA): immunologic and clinical significance. Semin. Arthritis Rheum. 6: 83-124.
3. TAN, E.M. 1989. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44: 93-151.
4. FERNANDEZ, S.A., A.Z. LOBO, Z.N. OLIVEIRA, et al. 2003. Prevalence of antinuclear autoantibodies in the serum of normal blood donors. Rev. Hosp. Clin. Fac. Med. Sao Paulo 58: 315-319.
5. WIIK, A.S. 2005. Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand. J. Rheumatol. 34: 260-268.
6. TAN, E.M. 1982. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv. Immunol. 33: 167-240.
7. CHRETIEN, P., M. DAUVIN, P. HELIN, et al. 1994. Comparison of indirect immunofluorescence on Crithidia luciliae of Farr test, and immunoenzymatic methods for the screening of anti-native DNA autoantibodies. Ann. Biol. Clin. (Paris) 52: 645-650.
8. DERKSEN, R.H., E.J. BAST, T. STROOISMA, et al. 2002. A comparison between the Farr radioimmunoassay and a new automated fluorescence immunoassay for the detection of antibodies against double stranded DNA in serum. Ann. Rheum. Dis. 61: 1099-1102.
9. HAUGBRO, K., J.C. NOSSENT, T. WINKLER, et al. 2004. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity. Ann. Rheum. Dis. 63: 386-394.
10. BULIARD, A., F. FORTENFANT, P. GHILLANI-DALBIN, et al. 2005. Analysis of nine autoantibodies associated with systemic autoimmune diseases using the Luminex technology. Results of a multicenter study. Ann. Biol. Clin. (Paris) 63: 51-58.
11. FULTON, R.J., R.L. MCDADE, P.L. SMITH, et al. 1997. Advanced multiplexed analysis with the FlowMetrix system. Clin. Chem. 43: 1749-1756.
12. GILBURD, B., M. ABU-SHAKRA, Y. SHOENFELD, et al. 2004. Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluation - a homogeneous, multiplexed system. Clin. Dev. Immunol. 11: 53-56.
13. GONZALEZ, C., B. GARCIA-BERROCAL, T. TALAVAN, et al. 2005. Clinical evaluation of a microsphere bead-based flow cytometry assay for the simultaneous determination of anti-thyroid peroxidase and anti-thyroglobulin antibodies. Clin. Biochem. 38: 966-972.
14. MARTINS, T.B., R. BURLINGAME, C.A. VON MUHLEN, et al. 2004. Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens. Clin. Diagn. Lab. Immunol. 11: 1054-1059.
15. NIFLI, A.P., G. NOTAS, M. MAMOULAKI, et al. 2006. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum. J. Immunol. Methods 3: 3.
16. ROUQUETTE, A.M., C. DESGRUELLES & P. LAROCHE. 2003. Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods. Am. J. Clin. Pathol. 120: 676-681.
17. SHOVMAN, O., B. GILBURD, G. ZANDMAN-GODDARD, et al. 2005. Multiplexed AtheNA multilyte immunoassay for ANA screening in autoimmune diseases. Autoimmunity 38: 105-109.
18. YIANNAKI, E.E., E. ZINTZARAS, A. ANALATOS, et al. 2004. Evaluation of a microsphere-based flow cytometric assay for diagnosis of celiac disease. J. Immunoassay Immunochem. 25: 345-357.
19. ZANDMAN-GODDARD, G., B. GILBURD, O. SHOVMAN, et al. 2005. The homogeneous multiplexed system - a new method for autoantibody profile in systemic lupus erythematosus. Clin. Dev. Immunol. 12: 107-111.
20. SHOVMAN, O., B. GILBURD, O. BARZILAI, et al. 2005. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann. N. Y. Acad. Sci. 1050: 380-388.
21. ISENBERG, D.A., C. DUDENEY, W. WILLIAMS, et al. 1987. Measurement of anti-DNA antibodies: a reappraisal using five different methods. Ann. Rheum. Dis. 46: 448-456.
22. SCOFIELD, R.H. 2004. Autoantibodies as predictors of disease. Lancet 363: 1544-1546.
23. GEISERT, M., B. HEICKE, E. METZMANN, et al. 1975. Influence of molecular weight of DNA on the determination of anti-DNA antibodies in systemic lupus erythematosus (SLE) sera by radioimmunoassay. Nucleic Acids Res. 2: 521-535.
24. BEN-CHETRIT, E., R.I. FOX & E.M. TAN. 1990. Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjogren's syndrome. Arthritis Rheum. 33: 349-355.
25. CHAN, E.K., J.C. HAMEL, J.P. BUYON, et al. 1991. Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J. Clin. Invest. 87: 68-76.
26. FRITSCH, C., J. HOEBEKE, H. DALI, et al. 2005. 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block. Arthritis Res. Ther. 8: R4.